Luzitin relies on partnering with several entities, with special emphasis on the following:
The University of Coimbra has a 7-century history and has been included in the UNESCO World Heritage list for its Outstanding Universal Value. Luzitin emerged from an R&D partnership between the University of Coimbra and Bluepharma, being an example of successful academia-to-industry technology transfer.
Since 1989, Omicron has been developing, building and producing innovative laser systems. With a highly qualified team, Omicron is the partner for the development of laser devices used in Luzitin's development programmes.
Aptuit is a pharmaceutical services company that delivers early discovery to mid-phase drug development solutions by applying scientific excellence, outstanding service and a team of some of the foremost scientific professionals in the industry. Aptuit has been the partner for the non-clinical GLP-compliant studies for LUZ11.
AAIPharma Services Corp. and Cambridge Major Laboratories, Inc. have joined to form Alcami, a world class supplier of comprehensive pharmaceutical development and manufacturing services. With seven sites across the globe, our combined capabilities include API development and manufacturing, solid state chemistry, formulation development, analytical development and testing services, clinical and commercial finished dosage form manufacturing (oral solid dose and parenteral), packaging, and stability services.